Related Articles
CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells
Hydroxyflutamide enhances cellular sensitivity to 5-fluorouracil by suppressing thymidylate synthase expression in bicalutamide-resistant human prostate cancer cells
Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models
Mutation and microsatellite instability analysis of the androgen receptor gene in human prostate cancer
The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells